Evidence map›Paper›PMID 35342450›Full record

ArticleJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences2022

The frequency, related cause of disease, and treatment of hepatitis B virus infection: A systematic review and meta-analysis in Iran.

Gholamreza Kalvandi, Ghobad Abangah, Yousef Veisani, Hassan Nourmohammadi, Mohamad Golitaleb, Hamed Tavan

Open access · goldAbstract read
In one paragraph

Article in Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Gholamreza KalvandiAssociate Professor of Pediatrics Gastroenterology Department of Pediatrics, School of Medicine Besat Hospital, Hamadan University of Medical Sciences, Hamadan, Iran.
Ghobad AbangahAssociate Professor of Gastroenterology and Hepatology, School of Medicine, Shahid Mostafa Khomaeini Hospital, Ilam University of Medical Sciences, Ilam, Iran.
Yousef VeisaniResearch Assistant Professor of Epidemiology Department of Epidemiology, School of Health Psychosocial Injuries Research Center Ilam University of Medical Sciences, Ilam, Iran.
Hassan NourmohammadiAssistant Professor of Hematology and Oncology, Department of Internal Medicine, School of Medicine,Shahid Mostafa Khomaeini Hospital, Ilam University of Medical Sciences, Ilam, Iran.
Mohamad GolitalebInstructor of Critical Care Nursing Department of Nursing, School of Nursing Arak University of Medical Sciences, Arak, Iran.
Hamed TavanMSs of nursing Medical-Surgical, Clinical Research Development Unit, Shahid Mostafa Khomeini Hospital, Ilam University of Medical Sciences, Ilam, Iran.
Ilam University · IRArak University of Medical Sciences · IRMedical University of Ilam · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hepatitis B virus (HBV) is one of the most dreadful viruses causing high mortality rates and serious damages to hepatocytes. The aim of this study was to assess the frequency, related causes/risk factors, and treatments of HBV infection in Iran by systematic review and meta-analysis. Materials and Methods: The data were obtained by a literature search in the PubMed, Scopus, SID, and Web of Sciences databases. Keywords included prevalence, risk factors, causes, treatment, and HBV. The Persian equivalents of these keywords were also searched. The time span included 2004 to2021. The Q and Results: The frequencies of HBV infection and its pharmaceutical therapy were Conclusion: The most important causes of HBV infection were transmission from infected people, narcotic consumption, and blood-related factors. The main therapeutic intervention for HBV was pharmaceutical therapy.

Indexed as

frequencyHepatitis B virusmeta-analysistreatment

Identifiers

PMID35342450
PMCPMC8943577
OpenAlexW4213066472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.